Half-year report · Q2
3154.TEDINET S100V7O6
Period2024-07-01 → 2024-12-31
Filed2025-02-12
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥142.7bn | 2024-07-01 → 2024-12-31 | Cons. | Net sales |
| Revenue | ¥259.8bn | 2023-07-01 → 2024-06-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥126.7bn | 2023-07-01 → 2023-12-31 | Cons. | Net sales |
| Operating income | ¥751m | 2024-07-01 → 2024-12-31 | Cons. | Operating income |
| Operating income | ¥681m | 2023-07-01 → 2023-12-31 | Cons. | Operating income |
| Ordinary income | ¥983m | 2024-07-01 → 2024-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.8bn | 2023-07-01 → 2024-06-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥900m | 2023-07-01 → 2023-12-31 | Cons. | Ordinary income |
| Profit before tax | ¥983m | 2024-07-01 → 2024-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥895m | 2023-07-01 → 2023-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥407m | 2024-07-01 → 2024-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.1bn | 2023-07-01 → 2024-06-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥505m | 2023-07-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥407m | 2024-07-01 → 2024-12-31 | Cons. | Profit loss |
| Net income | ¥505m | 2023-07-01 → 2023-12-31 | Cons. | Profit loss |
| Total assets | ¥119.8bn | at 2024-12-31 | Cons. | Assets |
| Total assets | ¥114.8bn | at 2024-06-30 | Cons. | Assets |
| Total assets | ¥112.6bn | at 2023-12-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥99.8bn | at 2024-12-31 | Cons. | Liabilities |
| Total liabilities | ¥95.1bn | at 2024-06-30 | Cons. | Liabilities |
| Net assets / equity | ¥20.0bn | at 2024-12-31 | Cons. | Net assets |
| Net assets / equity | ¥19.7bn | at 2024-06-30 | Cons. | Net assets |
| Net assets / equity | ¥18.6bn | at 2023-12-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥14.0bn | at 2024-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥13.6bn | at 2024-06-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥14.0bn | at 2024-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥13.5bn | at 2024-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥14.0bn | at 2023-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥10.3bn | at 2023-06-30d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥1.5bn | 2024-07-01 → 2024-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.9bn | 2023-07-01 → 2024-06-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥1.5bn | 2023-07-01 → 2023-12-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥1.4bn | 2024-07-01 → 2024-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥2.7bn | 2023-07-01 → 2024-06-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.5bn | 2023-07-01 → 2023-12-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥586m | 2024-07-01 → 2024-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥4.0bn | 2023-07-01 → 2024-06-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥6.7bn | 2023-07-01 → 2023-12-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥18.32 | 2024-07-01 → 2024-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥51.21 | 2023-07-01 → 2024-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥23.03 | 2023-07-01 → 2023-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥18.32 | 2024-07-01 → 2024-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥51 | 2023-07-01 → 2024-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥22.93 | 2023-07-01 → 2023-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 16.7% | at 2024-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 17.2% | at 2024-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 16.5% | at 2023-12-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 28
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2024-07-01 → 2024-12-31 | −¥9m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-07-01 → 2024-12-31 | −¥9m |
| Reconciling Itemsreconciling | segment profit | 2024-07-01 → 2024-12-31 | −¥4.5bn |
| jpcrp040300-q2r_E22995-000Medical Equipment Salesreportable segment | revenue | 2024-07-01 → 2024-12-31 | ¥139.7bn |
| jpcrp040300-q2r_E22995-000Medical Equipment Salesreportable segment | revenue external | 2024-07-01 → 2024-12-31 | ¥139.7bn |
| jpcrp040300-q2r_E22995-000Medical Equipment Salesreportable segment | revenue intersegment | 2024-07-01 → 2024-12-31 | ¥9m |
| jpcrp040300-q2r_E22995-000Medical Equipment Salesreportable segment | segment profit | 2024-07-01 → 2024-12-31 | ¥5.0bn |
| jpcrp040300-q2r_E22995-000Nursing Care And Welfarereportable segment | revenue | 2024-07-01 → 2024-12-31 | ¥3.0bn |
| jpcrp040300-q2r_E22995-000Nursing Care And Welfarereportable segment | revenue external | 2024-07-01 → 2024-12-31 | ¥3.0bn |
| jpcrp040300-q2r_E22995-000Nursing Care And Welfarereportable segment | segment profit | 2024-07-01 → 2024-12-31 | ¥250m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-07-01 → 2024-12-31 | ¥142.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-07-01 → 2024-12-31 | ¥142.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-07-01 → 2024-12-31 | ¥9m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-07-01 → 2024-12-31 | ¥5.3bn |
| Reconciling Itemsreconciling | revenue | 2023-07-01 → 2023-12-31 | −¥7m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-07-01 → 2023-12-31 | −¥7m |
| Reconciling Itemsreconciling | segment profit | 2023-07-01 → 2023-12-31 | −¥4.2bn |
| jpcrp040300-q2r_E22995-000Medical Equipment Salesreportable segment | revenue | 2023-07-01 → 2023-12-31 | ¥123.8bn |
| jpcrp040300-q2r_E22995-000Medical Equipment Salesreportable segment | revenue external | 2023-07-01 → 2023-12-31 | ¥123.8bn |
| jpcrp040300-q2r_E22995-000Medical Equipment Salesreportable segment | revenue intersegment | 2023-07-01 → 2023-12-31 | ¥7m |
| jpcrp040300-q2r_E22995-000Medical Equipment Salesreportable segment | segment profit | 2023-07-01 → 2023-12-31 | ¥4.6bn |
| jpcrp040300-q2r_E22995-000Nursing Care And Welfarereportable segment | revenue | 2023-07-01 → 2023-12-31 | ¥2.9bn |
| jpcrp040300-q2r_E22995-000Nursing Care And Welfarereportable segment | revenue external | 2023-07-01 → 2023-12-31 | ¥2.9bn |
| jpcrp040300-q2r_E22995-000Nursing Care And Welfarereportable segment | segment profit | 2023-07-01 → 2023-12-31 | ¥201m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-07-01 → 2023-12-31 | ¥126.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-07-01 → 2023-12-31 | ¥126.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-07-01 → 2023-12-31 | ¥7m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-07-01 → 2023-12-31 | ¥4.8bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 558
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)有限責任監査法人トーマツ | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)石 黒 宏 和 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)望 月 邦 彦 | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior1YTDDuration | 126713055000 | JPY |
| Net sales (5-year summary) | CurrentYTDDuration | 142704820000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 259789000000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YTDDuration | 899757000 | JPY |
| Ordinary income loss (5-year summary) | CurrentYTDDuration | 983194000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | 1750486000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YTDDuration | 505014000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | CurrentYTDDuration | 406751000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | 1124676000 | JPY |
| Comprehensive income (5-year summary) | Prior1YTDDuration | 514322000 | JPY |
| Comprehensive income (5-year summary) | CurrentYTDDuration | 678805000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | 1474890000 | JPY |
| Net assets (5-year summary) | Prior1QuarterInstant | 18604060000 | JPY |
| Net assets (5-year summary) | CurrentQuarterInstant | 19984601000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 19737425000 | JPY |
| Total assets (5-year summary) | Prior1QuarterInstant | 112609855000 | JPY |
| Total assets (5-year summary) | CurrentQuarterInstant | 119804733000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 114826794000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1YTDDuration | 23.03 | |
| Basic earnings loss per share (5-year summary) | CurrentYTDDuration | 18.32 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 51.21 | |
| Diluted earnings per share (5-year summary) | Prior1YTDDuration | 22.93 | |
| Diluted earnings per share (5-year summary) | CurrentYTDDuration | 18.32 | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | 51.00 | |
| Equity to asset ratio (5-year summary) | Prior1QuarterInstant | 0.165 | |
| Equity to asset ratio (5-year summary) | CurrentQuarterInstant | 0.167 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.172 | |
| Net cash provided by used in operating activities (5-year summary) | Prior1YTDDuration | -1502807000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | CurrentYTDDuration | 1482304000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior1YearDuration | 1921509000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YTDDuration | -1450793000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | CurrentYTDDuration | -1366922000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YearDuration | -2674476000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YTDDuration | 6670457000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | CurrentYTDDuration | 586498000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YearDuration | 4006276000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1QuarterInstant | 14008323000 | JPY |
| Cash and cash equivalents (5-year summary) | CurrentQuarterInstant | 13984668000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1YearInstant | 13544776000 | JPY |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 22238217 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 22238217 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 22238217 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 22238217 | |
| Number of shares held | CurrentQuarterInstant_No1MajorShareholdersMember | 2190000 | |
| Shareholding ratio | CurrentQuarterInstant_No1MajorShareholdersMember | 0.098 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |